Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients

Jennifer Walsh1, Anne Cram2, Katharina Woertz3

  • 1Jenny Walsh Consulting Ltd, BioCity Nottingham, Pennyfoot Street, Nottingham NG1 1GF, United Kingdom.

Insights

Developing paediatric medicines requires taste masking for better adherence. This review covers taste masking approaches for oral paediatric formulations, focusing on excipient safety and marketed examples.

Area of Science:

  • Pharmaceutical Sciences
  • Paediatric Drug Development

Background:

  • Paediatric drug development presents unique challenges due to diverse patient needs and differing physiological responses.
  • Ensuring palatability of oral paediatric medicines is crucial for patient adherence, a growing focus for regulatory bodies.
  • Many active pharmaceutical ingredients (APIs) possess undesirable tastes, necessitating effective taste masking strategies.

Purpose of the Study:

  • To review various taste masking techniques for active pharmaceutical ingredients (APIs) in paediatric oral dosage forms.
  • To emphasize the tolerability and safety of excipients used in these taste-masked formulations.
  • To provide examples of commercially available paediatric oral medicines employing taste masking.

Main Methods:

  • Literature review of scientific databases and regulatory guidelines.
  • Analysis of taste masking technologies applied to paediatric oral formulations.
  • Evaluation of excipient safety profiles in paediatric populations.
  • Identification and assessment of marketed paediatric oral products with taste-masked APIs.

Main Results:

  • Multiple taste masking approaches exist, including microencapsulation, complexation, and formulation strategies.
  • Excipient selection is critical, requiring careful consideration of paediatric-specific tolerability and safety data.
  • Successful taste masking can significantly improve the palatability and acceptance of paediatric medicines.
  • Several marketed products demonstrate effective taste masking for paediatric use.

Conclusions:

  • Taste masking is essential for palatable paediatric oral medicines, enhancing adherence.
  • A thorough understanding of API characteristics and excipient safety is vital for successful paediatric formulation.
  • Continued research and development in taste masking technologies are needed to meet the specific needs of paediatric patients.

Related Concept Videos

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
241
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
226
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
279